Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02936791 · ClinicalTrials.gov registry record
Early PKD Observational Cohort Study
A clinical trial of Polycystic Kidney Disease, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 250
- Enrollment target
- 3
- Study locations
NCT02936791: Recruiting study of Polycystic Kidney Disease, sponsored by University of Kansas Medical Center.
NCT02936791 is a study of Polycystic Kidney Disease that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 250 participants, below the 283-participant average among 5 other Polycystic Kidney Disease trials with a reported enrollment target (12% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02936791, a study of Polycystic Kidney Disease, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 3
- Study locations
Study Summary
This observational study will collect blood and urine and clinical information from individuals with early-stages of polycystic kidney disease (PKD), their unaffected siblings and normal volunteers to create a biobank, also called a biorepository. The long-term goal is to develop new knowledge on biological markers or biomarkers that indicate changes in the disease progression. An understanding of biomarkers for early renal cyst growth will benefit PKD patients as new therapies are being developed and tested.
Primary Outcome
The study will establish a repository of blood and urine from individuals with early stage PKD, unaffected/undiagnosed family members and normal volunteers.
Conditions Studied
Study Locations (3)
Illinois
- University of Chicago - Chicago
Kansas
- University of Kansas Medical Center - Kansas City
Missouri
- Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2016-04 |
| Est. Completion | 2026-06 |
What NCT02936791 shows while recruiting
NCT02936791 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 283-participant average among 5 other Polycystic Kidney Disease trials with a reported enrollment target (12% lower).
The record links to 1 condition, with Polycystic Kidney Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02936791 reports a single indexed study location in Illinois, Kansas, Missouri.
Frequently Asked Questions
What is clinical trial NCT02936791 about?
NCT02936791 is a clinical study titled "Early PKD Observational Cohort Study". This observational study will collect blood and urine and clinical information from individuals with early-stages of polycystic kidney disease (PKD), their unaffected siblings and normal volunteers to create a biobank, also called a biorepository. The long-term goal is to develop new knowledge on bi...
What is the current status of trial NCT02936791?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2016-04. Estimated completion is 2026-06.
What conditions does trial NCT02936791 study?
This clinical trial studies the following conditions: Polycystic Kidney Disease.
Who is sponsoring clinical trial NCT02936791?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02936791 being conducted?
This trial has 3 study locations across Illinois, Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polycystic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PKD Clinical and Translational Core Study
RECRUITING
-
Polycystic Kidney Disease Data Repository
RECRUITING
-
Well-Formulated Ketogenic Diet Polycystic Kidney Disease
RECRUITING · NA
-
Amnioinfusion for Fetal Renal Failure
RECRUITING · NA
-
Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia